Interferon-α2b Treatment for COVID-19

Interferon-α2b Treatment for COVID-19

The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon (IFN)-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China. In this uncontrolled, exploratory study, 77 adul...

Full description

Bibliographic Details
Main Authors: Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, Zi-Hao Wang, Scott J. Tebbutt, Tobias R. Kollmann, Eleanor N. Fish
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Immunology
Subjects:
interferon
COVID-19
viral shedding
IL-6
inflammation
ARDS
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01061/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.01061/full

Similar Items